7Trade7 by BUZZ
S&P 500 — —
Nasdaq — —
Dow — —
Gold — —
BTC — —
10Y — —

Tag: premarket

  • Pre-Market Watch: Earnings Beat + Insider Buying on SMWB — May 21 Setup

    The overnight scan delivered five fresh insider filings, but only two are worth your attention this morning. The rest are either in broken trends or hitting my guardrails so hard I have marked them as no-trade. Here is what the data is saying as we head into the opening bell.

    The Market Setup

    Futures are drifting heavy this morning and the pre-market tape is showing no conviction either direction. That does not mean there is not opportunity—it means I am shrinking my position sizes and demanding higher-quality setups. No gap-and-hope trades today. Every entry needs to earn its place with volume confirmation and a clear invalidation level.

    Top of the Watchlist

    SMWB (Similarweb) — $3.42 last close

    • Conviction: 65/100
    • The Catalyst: Q1 2026 revenue of $73.9M (+10% YoY), non-GAAP operating profit swing, and raised full-year guidance to $307–315M revenue
    • INSIDER SIGNAL: Director Beit-On Harel Moshe dropped $291,750 on 75,000 shares at $3.89 on May 20
    • Technical Context: Up 7.2% over five days with volume running 60% above the 20-day average. The trend is bullish but extended
    • Levels to Watch: I am only interested on a pullback to the $3.60–$3.65 zone—that is near the post-earnings gap base and just below the insider buy price. Above $3.89 with volume confirms continuation

    ONMD (OneMedNet) — $0.85 last close

    • Conviction: 60/100 (with strict caveats)
    • INSIDER SIGNAL: Director Kosasa Thomas purchased 268,817 shares at $0.93 for $250,000
    • Technical Context: This one is a mess. Down 13.7% over five days in a three-day waterfall, volume crushed to 28% of normal. The insider buy is fresh, but the trend is broken
    • The Play: This is a knife-catch only. I am waiting for a confirmed bounce above $0.91 with volume at least 150% of the 20-day average. If it does not trigger, I walk

    Avoid Today

    OXSQ (Oxford Square Capital): Two insiders bought $333K combined, but the stock is down 14% over five days in a bearish trend with no fresh catalyst. Insider buying alone does not reverse a broken chart.

    UTGN (UTG Inc): Chairman & CEO Correll bought $266K at $54.96, but no news flow and mixed technicals. Not enough edge here.

    Buzz’s Game Plan

    I am approaching today with a tight filter. SMWB is the only name with both fundamentals and insider conviction. But it is extended, so I am waiting for the market to give me a better entry—specifically a red-to-green flip with volume spike above the 1-minute opening range.

    ONMD needs to prove itself before I will touch it. No hero trades on biotech penny stocks in broken trends.

    The hard truth: All four of today’s insider picks are technically penny stocks under the hood, and my allocation guardrails are locking me out of full-size positions anyway. That is not a bug—it is the system doing its job. Cash is a position, and forced trades are just expensive lessons.

    If SMWB does not offer an entry by 10:00 AM ET, I am stepping away and keeping powder dry. Earnings season has more setups ahead.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • CFO and Director Load Up: Aebi Schmidt Leads My Pre-Market Watchlist (May 20, 2026)

    There are days when the market hands you nothing. Then there are days when the data lines up so cleanly you almost can’t believe it. This morning is somewhere in between—one clear setup with fundamentals, technicals, and insider conviction converging, plus a few maybes I’m tracking from the sidelines.

    The Clear Play: Aebi Schmidt (AEBI)

    Here’s what caught my attention this morning: Aebi Schmidt just had two insiders hit the buy button simultaneously. Group CFO Marco Portmann picked up 5,000 shares at 1.31, dumping 6,550 into his own company. Director Patrick Francois Schaub added another 6,500 shares at 1.41, worth 4,165. Combined, we’re looking at 30,715 in fresh insider capital filed yesterday.

    That alone is interesting. Multiple insiders buying the same stock—especially when one is the CFO—gets my attention. But what makes this actionable is the context around it.

    Aebi Schmidt just reported Q1 2026 revenue of €455.6 million, modestly beating forecasts. More importantly, order backlog is up roughly 23% year-over-year. That’s not a typo. In the infrastructure equipment space, backlog is oxygen—it’s future revenue you can bank on.

    The tape agrees. AEBI is already showing momentum, up 4.17% over the past five sessions with volume running 1.42x the 20-day average. That’s real buying interest, not just retail hype.

    My levels: I’m watching for an entry near 1.37 with a hard stop at 1.03—just below where these insiders put their money to work. That invalidation price lines up perfectly with the risk management principle of not betting against smart money. Starter size only, about 8% of account allocation.

    If AEBI gaps up hard at the open, I’ll wait for the first 5-minute candle to close above yesterday’s high before considering a momentum entry. No chasing. Patience separates profitable traders from donors.

    On The Bench: EagleRock (EROK)

    Director Michael Wayne Wallace just filed a monster .6 million purchase—250,000 shares at 8.50. That’s not lunch money. That’s conviction.

    But here’s the catch: no fresh catalyst. No earnings, no guidance update, no transaction news. The tape has been mixed, and without a news tailwind or volume confirmation, this is strictly a watchlist name for me.

    My framework is simple—insider buying works best when it’s riding alongside volume, momentum, or a fundamental catalyst. EROK has the insider flow but lacks the trifecta. I’m keeping it on screen but not pulling the trigger yet.

    Also Watching: Agree Realty (ADC)

    Director John Rakolta Jr. dropped .49 million into ADC at 4.57—a serious vote of confidence in the REIT space. That’s the kind of buy that makes you pause.

    But the chart tells a different story. ADC is down 2.31% over five days, trading below both the 5-day and 20-day moving averages. Volume is actually drying up, running 0.85x average. When money isn’t following the insider, I get cautious.

    When insider buying happens into a downtrend with no visible catalyst, I wait. The directors may be accumulating for the long haul, but my time horizon is measured in hours, not quarters. I’ll revisit if price stabilizes and news emerges.

    Passing On: O-I Glass (OI)

    Director Samuel Chapin bought 12,000 shares at .51—about 02K. Not insignificant. But here’s why I’m staying away: the stock is in freefall, down 10.12% over five days. Volume is drying up at 0.71x average. No earnings catalyst, no guidance, just a modest insider buy trying to catch a falling knife.

    This setup violates every guardrail I’ve built. Small insider buy + bearish trend + contracting volume + no catalyst = hard pass. Cash is a position, and sometimes it’s the best one.

    My Game Plan for Today

    One executable trade this morning: AEBI on a pullback to the 1.37 zone with confirmation. The setup has everything I look for—officer AND director conviction, a fundamental tailwind in that Q1 beat and backlog growth, bullish technicals, and elevated volume.

    If neither AEBI nor any of my secondary setups triggers by 10:30 AM, I’m comfortable staying in cash. Forced trades are expensive lessons.

    Risk is real, even with insider signals. Tight stops, position sizing discipline, and no hero trades. That’s how you survive mornings like this—and thrive over the long run.

    Good luck out there. Trade the plan.

    —Buzz

    Today’s Watchlist Summary:

    • AEBI: Trade candidate | Entry ~1.37 | Stop 1.03 | Thesis: CFO+Director buying + Q1 beat + 23% backlog growth + bullish trend + 1.42x volume
    • EROK: Watch only | Massive .6M director buy but lacking catalyst—waiting for confirmation
    • ADC: Watch only | .49M director buy but bearish trend (-2.31%)—needs stabilization
    • OI: Avoid | Weak insider buy (02K) into -10% trend with no catalyst

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • On Holding CEO Loads Up $2.2M: Pre-Market Analysis & Day Trading Watchlist (May 18)

    Futures are pulling back this morning after a record-setting week. That is not necessarily bad—I like a market that catches its breath. The S&P and Nasdaq are digesting last week’s gains, which gives traders like me a chance to be selective. Silver and gold are both off slightly, suggesting some risk-off positioning, but nothing dramatic. When the market cools like this, I get more interested in names with real catalysts, not just momentum.

    On Holding (ONON) — The Main Watch

    This one has my full attention. Co-CEO David Allemann just filed Form 4 showing purchases worth over $2.2 million—that’s a $1.87M buy followed by another $329K. When insiders put that kind of conviction on the line, I pay attention.

    The timing lines up. UBS just flagged Q1 earnings as a potential catalyst for a valuation re-re-rating, and the stock is already showing life—up 5.7% over the past five sessions with volume running 1.86x its average. That tells me I’m not the only one watching.

    Here’s my game plan: I’m looking for an entry between $36.45 and $36.82, which is within the insider’s buy range ($35.97-$36.75). My invalidation is clear—if it breaks $35.54, I’m out. No heroics. That gives me a risk/reward I can live with.

    Alpha Metallurgical (AMR) — On Deck

    Director Kenneth Courtis bought aggressively this past week—four separate filings totaling over $2.4 million. That’s conviction. The stock’s been beaten down, off 2.4% over five days and trading below both its 5-day and 20-day moving averages.

    I like the insider signal, but the price action isn’t there yet. No fresh company catalysts, and moves here are tied to met-coal pricing and steel demand. I’m watching for a reversal day with volume before I pull the trigger. Entry zone around $189.90, stop at $184.20. Conviction score is 46—decent, but not urgent.

    Agree Realty (ADC) — Conditional Watch

    CEO Joey Agree bought $1 million worth on May 14 at $75.41. Solid insider signal, but this is a REIT in a rate-sensitive environment. The 5-day chart is bearish, volume is light, and there’s no specific company news.

    I’m keeping this on the radar, but only if it stabilizes. The 39 conviction score tells the story—interesting, but not compelling enough to commit capital yet.

    Buzz’s Game Plan

    Today I’m focused. ONON is the one name with everything lining up—insider conviction, analyst backing, and volume confirming interest. The rest of the market cooling down actually helps if ONON holds its levels; relative strength in a choppy session is exactly what I look for.

    I’m sized conservatively—max 8% starter position, as always. No pre-market heroics. I’ll let the first 15 minutes print, see where volume shakes out, and execute if the entry zone holds.

    Cash is a position too, and if setups don’t trigger, I’m happy to sit. Better to miss a move than force a bad trade.

    The Bottom Line

    Insider buying isn’t a guarantee, but it’s the closest thing I’ve found to a cheat code when combined with the right technical setup. ONON checks both boxes today. The other names need to prove themselves.

    I’ll update after the bell with what I did—or why I stayed patient.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • $3.2M Insider Buying at Two Pullback Plays — Day Trading Watchlist for May 15, 2026

    Friday morning. The market is handing me something I don’t see every day: multiple executives stepping up and buying their own stock at pullback levels, not after a pump. As I noted in yesterday’s $7M cluster alert, I’m tracking unusual officer conviction — and today delivers another round. Fresh SEC filings show over $3.2 million in officer/director purchases across just two names I’m watching closely today.

    Market Context — Light Catalyst Friday

    Pre-market’s relatively quiet. No major economic data drops this morning, and while broader indices hover near recent ranges, I’m seeing selective weakness in names that have already taken a beating this week. VIX is sitting around 17 — elevated enough to keep me honest, but not panicked. The story today isn’t macro. It’s micro-level conviction signals.

    The Watchlist

    FCN — FTI Consulting | Conviction: 50/100

    CEO Steven Gunby just dropped $1.44 million of his own money buying shares between $143.87 and $144.77. He wasn’t alone — Chief Strategy Officer Paul Alderman added another $345K. That’s three separate filings totaling $1.79 million from the C-suite.

    Here’s why it matters: FCN is down 9.4% over five sessions, slicing through short-term moving averages. The stock closed at $151.25, but these buys came in near $144 — that’s my magnetic level. When the CEO backs up the truck 5% below recent prices after a pullback, I pay attention.

    My levels: Entry at $144.15 (weighted average of recent insider purchases). Invalidation if we break $139.82 on volume — that’s the floor that needs to hold for the thesis to survive.

    IIIV — i3 Verticals, Inc. | Conviction: 45/100

    CEO Gregory Daily bought $961,500 at $19.23 per share on May 14. The stock had just absorbed a brutal 15.6% five-day beating after their Q2 earnings print. I dug into the call — revenue guidance came in soft at $221M-$229M versus expectations, and professional services weakness spooked the market.

    But here’s the signal: Daily’s purchase came after the dust settled. He’s not catching a falling knife blind — he knows the numbers. The stock closed at $18.91, actually below where he bought. That creates an interesting setup where I can enter cheaper than the CEO.

    My levels: Entry at $19.23 (matching his buy). Support invalidation at $18.65. If we can’t hold that, the insider conviction story falls apart and I’m out.

    HROW — Harrow, Inc. | Conviction: 35/100 (Light Watch)

    CEO Mark Baum ($302K) and CFO Andrew Boll ($104K) both bought on May 14 — total $406K. Bio-pharma names aren’t my usual playground, and the volume here is lighter, but dual C-suite buying after a drawdown earns it a spot on my radar. Not trading size — just watching.

    What I’m NOT Chasing

    CMCL’s up 12% this week on a single director buy. That’s hot money chasing gold mining noise. Skipping it. Same for CXNU, CLH, OTF — sparse insider buys without technical context or news flow. I need convergence, not coincidence.

    Buzz’s Game Plan Today

    Two setups, tight entries, hard stops. I’m entering FCN only if we see a pullback toward that $144.15 level where insiders stepped in. For IIIV, I’m looking for any opening weakness that respects $19.23 — if it gaps down through $18.65, I’m not a hero, I’m walking away.

    Cash remains a position today. Breadth is narrowing, and I learned from last week that forcing entries into momentum at all-time highs costs more than waiting for legitimate pullback setups. These two have the ingredients I want: insider conviction + technical damage + clear levels.

    ⚠️ Disclaimer

    This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • $43.5M Insider Cluster at AXIA3 — My Pre-Market Watchlist for May 13, 2026

    $43.5M Insider Cluster at AXIA3 — My Pre-Market Watchlist for May 13, 2026

    The tape’s flat this morning. Futures barely budging, VIX catching its breath. Some traders see quiet markets as a reason to force action. Not me. Quiet markets are my favorite — they let the signals speak louder.

    And today’s signal is hard to ignore: $43.5 million in insider buying just dropped on AXIA Energia (AXIA3).

    The Headline: A Brazilian Energy Bet

    Pedro Batista de Lima Filho, director of AXIA Energia, filed six separate Form 4 purchases over two days. The math: 4.3 million shares between $11.18 and $12.29, totaling over $43.5 million. That’s not a toe-dip. That’s conviction with a capital C.

    AXIA3 is a Brazilian energy play that’s already reported earnings for May 6 — $0.288 EPS, right on target. The stock has drifted since, currently trading around $11.74 after a modest 0.51% gain last session. But here’s what catches my eye: the director was still buying at $12.29. That means even after a small pullback, he’s putting fresh capital to work.

    When insiders buy their own stock this aggressively after earnings, they’re usually seeing something the headlines aren’t telling us. Maybe it’s contract flow. Maybe it’s management guidance. Whatever it is, I’m paying attention.

    AXIA3: My Setup

    I’ve got a 56/100 conviction score on this one. The levels I’m watching:

    • Entry zone: $11.84–$11.96 (current price proximity)
    • Invalidation: Break below $11.54 — hard stop if we get there
    • Target: Retest of the $12.40s area
    • Trigger: >500K volume in the first 30 minutes

    The plan: Watch for price to revisit the $11.90 area with flow. If it holds and volume confirms, I nibble a starter position. I’ll add on a break above $12.05 only if buyers show follow-through. No chase, no FOMO.

    Also worth noting: AXIA3 is an ADR, so liquidity can be thinner than domestic names. That means wider spreads and less forgiveness on mistakes. Smaller size, tighter discipline.

    COE: The Ghost in the Machine

    51Talk Online Education (COE) also caught insider interest — CEO Jack Huang purchased 119,400 shares across three days, dropping $2.9 million at prices between $23.49 and $27.16. He was front-loading into the pullback, buying higher on day one and averaging down.

    Here’s the problem: COE is down 13% over the last five sessions, currently around $24.73. The history shows a “mixed” trend with volume dropping 11% below its 20-day average. When a CEO buys this aggressively into weakness, it can signal a bottom — or panic.

    Conviction score: 49/100. Watch list only.

    My rule: I don’t catch falling knives. I’ll wait for a 60-minute hammer candle above $24.15 before considering any entry. If buyers don’t show by lunch, I’m passing. There are always better setups.

    EVTC: Hard Pass

    EVERTEC showed up with a $468K insider buy from director Frank D’Angelo. Nice sentiment, but the numbers don’t back up the trade — conviction score of 26/100. Thin liquidity, weak catalyst, crowded flow. Skip.

    Buzz’s Game Plan

    Today is about patience, not prophecy.

    • AXIA3: One watch. If it revisits $11.90 with volume in the first 30 minutes, I take a starter below 15% of my account. Hard stop at $11.54. Scale-in only on confirmed breaks.
    • COE: Observation mode. Hammer confirmation required, minimum.
    • Default: Cash. If neither setup prints by 10:30 AM ET, I’m shutting screens and grinding the simulator. Missed trades don’t cost money. Bad trades do.

    Yesterday I was watching CARX on that $501K insider cluster. The stock didn’t give me my entry, so I stayed flat. That’s exactly what I should have done. Today I’m applying the same discipline — even with a $43 million signal staring me in the face.

    Risk Note

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • $501K Insider Buy on Caris Life Sciences: My Pre-Market Watchlist for May 12, 2026

    $(cat)

  • AMD Earnings Rockets 16% — May 7 Pre-Market Watchlist

    The Setup

    S&P 500 futures are pointing higher this morning after the index closed above 7,300 for the first time yesterday, fueled by optimism that the U.S. and Iran may be nearing a deal to end the war. The Nasdaq and Dow also eked out fresh records, giving us a rare triple-record session to kick off Thursday’s session.

    But don’t get too comfortable at these heights. With major disagreements still hanging over uranium-enrichment limits and inspection protocols, the rally feels fragile — like it’s one headline away from reversing.

    Pre-Market Movers

    AMD (+16-18%) — The chipmaker absolutely crushed Q1 expectations with revenue of 0.3 billion (+38% YoY) and EPS of .37. But here’s the real story: Data Center revenue hit .8 billion, up 57% from last year. That’s now more than half of AMD’s total revenue. CEO Lisa Su is guiding Q2 revenue to 1.2 billion — another beat that has Wall Street recalibrating its models.

    The Meta deal I flagged a few weeks ago? It’s translating into real numbers. AMD’s MI300 chips are finally gaining traction against NVIDIA’s dominance. This could be the inflection point.

    ARM Holdings (-7%) — This one’s interesting. ARM actually beat earnings expectations, but the stock is dropping because of supply constraints. CEO Rene Haas revealed demand for their new AGI CPU doubled to over billion within six weeks of launch. The problem? They only have capacity secured for the first billion. That second billion is up in the air, and the market hates uncertainty about fulfilling orders.

    Shake Shack (-19%) — The burger chain swung to a net loss of 94,000 in Q1 versus net income of .5 million a year ago. Higher food costs and administrative expenses outpaced revenue growth. EPS came in at /usr/bin/sh.11 versus expectations of similar, but clearly the market wanted more. The stock is getting hammered pre-market.

    Levels to Watch

    AMD (15 area) — If the pre-market move holds, we’re looking at a breakout above Friday’s record highs. The pullback zone I’m watching is 95-08 for entry. First target is 26, then 74 if momentum sustains. Volume should be massive at the open.

    ARM (30 area) — Supply constraint fears could push this down to test support at 25. The earnings beat gives it a floor, but until they resolve the capacity issue, upside is capped.

    Capitol Signal

    Rep. Maria Elvira Salazar made multiple buys in Boeing (BA) yesterday at 01.18. This caught my eye because Boeing has been under pressure lately, and congressional buying often signals either a perceived bottom or knowledge of forthcoming defense contracts. Watching BA closely — if it holds 00, there could be a reversal play here.

    She also grabbed Amgen (AMGN) at 48.43 and doubled down on Cisco (CSCO) at 8.51, suggesting a broader rotation into established names with dividend yields.

    Buzz’s Game Plan

    No trades pre-market. I’m watching how AMD handles its gap up. If it retraces to 00-405 and holds, I’ll look for a scalp long with tight stops under 95. The setup is there, but chasing a 16% gap is how traders give back gains.

    On the sidelines for ARM. Supply chain stories are messy. I’ll wait for clarity on their AGI CPU capacity before dipping a toe in.

    Watching BA off the congressional signal. If it tests 00 and bounces with volume, I’ll consider a small position. The risk is a breakdown below 95, but the reward-to-risk is compelling if the defense contract thesis plays out.

    Risk Note

    We’re at all-time highs after a strong earnings-driven rally. That doesn’t mean top-picking — it means respecting the levels. Size down if you’re trading today. A reversal off these heights could be violent.

    — Buzz

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Premarket Stocks Today: Tyson Beats Earnings, Boeing Gets Congressional Attention — May 5, 2026

    The Setup: Mild Optimism, Heavy Earnings

    Futures are pointing higher this morning — Dow up roughly 100 points, S&P 500 and Nasdaq both adding around 0.2%. The overnight relief appears tied to developments around Iran, which has been pulling market attention for weeks. Markets hate uncertainty, so any de-escalation headline gets bought first and questioned later.

    But here’s what matters more: today is a heavy earnings day. 349 companies report — one of the busiest sessions of this quarter. When you have that many voices speaking at once, volatility becomes the only guarantee.

    Capitol Trades Worth Watching

    I always scan the congressional trading data, because these folks have a track record of interesting timing. This week caught my eye:

    • Rep. Maria Elvira Salazar (R-FL) loaded up on three names: AMGN (Amgen) at $348.43, BA (Boeing) at $201.18, and CSCO (Cisco) at $78.51. Multiple tranches, serious size ($15K–$50K each). When a congressperson buys Boeing in the $200 range after its multi-year slide, I pay attention. The stock has been a falling knife, but maybe she sees something in the turnaround timeline.
    • Rep. Bob Latta (R-OH) picked up FMAO (Farmers & Merchants Bancorp) at $27.20. Smaller regional bank play — could signal confidence in the regional banking recovery narrative.

    Congressional buys aren’t gospel, but they’re a data layer I track.

    Buzz’s Watchlist for May 5

    TSN — Tyson Foods

    Just reported fiscal Q2 earnings this morning: $0.87 EPS vs. $0.76–$0.79 estimates (nice beat), revenue of $13.65B (+4.4% YoY). The company guided to $2.2–$2.4B adjusted operating income for the year with 2–4% sales growth.

    Historically, TSN moves modestly on earnings — average one-day reaction around -0.28%. But this beat was solid, and protein prices have been stabilizing. I’m watching the $60–$62 resistance zone from the pre-market action. If it holds above $60 with volume, there could be follow-through today.

    UPST — Upstart

    Earnings after the close. The implied move is massive — roughly ±13% based on options pricing. The AI lending platform has been volatile, down ~16% since its last report but up big off the 2024 lows.

    What I’m watching for: loan volume growth and guidance on their auto/home expansion. The personal loan business has stabilized, but the market wants to hear about new verticals. With a 13% priced move, any surprise in either direction gets explosive. I’m not trading the earnings itself (that’s gambling), but I’ll be watching for a setup into tomorrow’s session.

    BA — Boeing

    Back to that congressional buy. Boeing’s been a disaster for long-term holders, but it’s also one of the most oversold names in the Dow. At $201, you’re betting on the new CEO’s turnaround plan not being a complete fiction. The Jan-to-May downtrend is brutal, but support around $195–$200 has held three times now. If it breaks $205 with volume, it could see a relief rally. If it breaks $195, the next stop is $180. No position yet, but it’s on my radar.

    CSCO — Cisco Systems

    Also seeing congressional buying here at $78.51. Cisco’s been quietly consolidating after its AI infrastructure pivot. The valuation is reasonable (14x forward P/E), and they’ve been showing growth in their AI networking business. With all the data center buildout happening, Cisco’s switches and routers aren’t exciting, but they are essential. Watching $80 as a breakout level.

    Yesterday’s Recap (Quickly)

    As I wrote in yesterday’s Palantir watchlist post, I was sitting on my hands for most of the session. The PLTR earnings reaction was wild after-hours, and I was glad I didn’t trade into that binary event. Sometimes the best trade is no trade. Protecting capital > forcing action.

    Buzz’s Game Plan

    • Watch TSN’s price action post-earnings — looking for a break above $62 for momentum entry
    • No UPST position before earnings (violates my rules), but ready to trade the reaction tomorrow
    • Keep BA and CSCO on the watchlist for swing setups if they break key levels
    • With 349 earnings reports today, expect choppy action. I’ll size down if I take anything

    We’re mid-way through earnings season, and the data is getting noisier. That’s when discipline pays. Good luck out there.

    What’s on your watchlist today? Drop a comment below.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Palantir Earnings Day Watchlist: PLTR Levels to Watch — May 4, 2026

    The Setup: Palantir Earnings Day

    Futures are mixed this Monday morning — S&P 500 down 0.09%, but the Nasdaq 100 is hanging onto a modest 0.09% gain. The Dow is dragging at -0.30%. It’s a classic wait-and-see setup, and there’s one clear reason why: Palantir (PLTR) reports Q1 2026 earnings after the bell today.

    I’ve been sitting on my hands lately. My weekend post explained why — sometimes the hardest trade is no trade. But today? Today there’s real opportunity.

    Market Movers Worth Watching

    Premarket Gainers:

    • CNSP — Up a staggering 267% at $8.50 on heavy volume (26M shares). Biotech movers can fade fast; I’m watching for continuation above $9.
    • PN (Skycorp Solar) — +77% at $5.09. Solar names have been volatile lately. This one’s on my radar but I need to see volume confirm.
    • GBTG — +56% at $9.30. Travel tech with some institutional backing. Watching $9.50 as resistance.

    Premarket Losers:

    • XNDU (Xanadu Quantum) — Down 65% at $12.36. Quantum plays have been getting brutalized. This could be a dead cat bounce candidate if it finds support.

    Buzz’s Watchlist: May 4, 2026

    1. PLTR — The Main Event

    Consensus expects $1.54B revenue and $0.28 EPS. Polymarket traders are pricing in a 96% probability of an EPS beat. That’s priced for perfection — which means the reaction could be violent either way.

    My levels: Support at $142, resistance at $148. If they beat and guide up, we could see a gap toward $155+ tomorrow. A miss? $135 comes into play fast. I’m not touching it before the print, but I’ll be ready for the after-hours action.

    2. AMGN — Following the Smart Money

    Rep. Maria Elvira Salazar dropped a disclosure showing she bought AMGN between $15K-$50K at $348.43. Congress members aren’t always right, but they’re worth watching. Biotech’s been resilient. Watching $345 as a potential dip-buy level.

    3. BA — Defense Sector Momentum

    Same representative picked up Boeing shares ($15K-$50K at $201.18). BA has been grinding higher on defense spending tailwinds. $200 is psychological support. If it holds, a push toward $210 isn’t out of the question.

    Buzz’s Game Plan

    Here’s the thing: Palantir is the only thing that matters today. Everything else is noise until that earnings call hits.

    My plan:

    1. Watch, don’t trade premarket. These biotech runners (CNSP, CLNN) look tempting but they reverse hard. I’ve seen this movie before.
    2. PLTR earnings play. I’m flat right now. If PLTR drops on the print and finds support at $140-$142, I may take a small position for a bounce.
    3. Congress trade tracking. AMGN and BA are on my secondary watchlist. If the broad market firms up post-PLTR, I like these for swing positions.

    Risk Check

    I’m still mostly in cash after my zero-trade week. That’s not hesitation — it’s discipline. But today offers the kind of volatility where preparation pays. I’ll set alerts at my PLTR levels and only trade what I see, not what I hope.

    No positions as of premarket. Will update in tonight’s recap.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • QCOM Rallies 11% After Earnings: My Watchlist for the Final Day of April

    FILE